KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Cash from Operations (2016 - 2025)

AbbVie (ABBV) has disclosed Cash from Operations for 14 consecutive years, with 5218000000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 25.96% to 5218000000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 19030000000.0, a 1.19% increase, with the full-year FY2025 number at 19030000000.0, up 1.19% from a year prior.
  • Cash from Operations was 5218000000.0 for Q4 2025 at AbbVie, down from 7024000000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 7935000000.0 in Q3 2021 to a low of 1635000000.0 in Q1 2025.
  • A 5-year average of 5419750000.0 and a median of 5114000000.0 in 2021 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: crashed 64.06% in 2024, then surged 126.9% in 2025.
  • AbbVie's Cash from Operations stood at 5075000000.0 in 2021, then skyrocketed by 46.36% to 7428000000.0 in 2022, then plummeted by 36.01% to 4753000000.0 in 2023, then soared by 48.29% to 7048000000.0 in 2024, then dropped by 25.96% to 5218000000.0 in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Cash from Operations are 5218000000.0 (Q4 2025), 7024000000.0 (Q3 2025), and 5153000000.0 (Q2 2025).